METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received one or more prior anti-HER2 based therapies approved for use through the Cancer Drugs Fund in NHS in England.
If a person has a heart attack, do they get told that they will never have a heart attack again and they are free of heart disease?
METUPUK was over the moon to receive an amazing donation from Hearts & Hope 4 Helen. The cheque was handed over to METUPUK at the Darker Pink exhibition, which is currently in the Michell Library in Glasgow.
